Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ABSTINENCE SYNDROME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lifshitz, M; Gavrilov, V; Galil, A; Landau, D
      A four year survey of neonatal narcotic withdrawals: Evaluation and treatment

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    2. Yesilyurt, O; Uzbay, IT
      Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice

      NEUROPSYCHOPHARMACOLOGY
    3. Koob, GF; Le Moal, M
      Drug addiction, dysregulation of reward, and allostasis

      NEUROPSYCHOPHARMACOLOGY
    4. Johnson, RE; Jones, HE; Jasinski, DR; Svikis, DS; Haug, NA; Jansson, LM; Kissin, WB; Alpan, G; Lantz, ME; Cone, EJ; Wilkins, DG; Golden, AS; Huggins, GR; Lester, BM
      Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes

      DRUG AND ALCOHOL DEPENDENCE
    5. Schmidt, BL; Tambeli, CH; Gear, RW; Levine, JD
      Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens

      NEUROSCIENCE
    6. Uzbay, IT; Oglesby, MW
      Nitric oxide and substance dependence

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    7. Lohmann, AB; Smith, FL
      Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups

      PEDIATRIC RESEARCH
    8. Clark, A; Lindgren, S; Brooks, SP; Watson, WP; Little, HJ
      Chronic infusion of nicotine can increase operant self-administration of alcohol

      NEUROPHARMACOLOGY
    9. Prokai, L; Prokai-Tatrai, K; Zharikova, A; Li, XX; Rocca, JR
      Combinatorial lead optimization of a neuropeptide FF antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    10. Carlson, J; Noguchi, K; Ellison, G
      Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus

      BRAIN RESEARCH
    11. Rada, P; Jensen, K; Hoebel, BG
      Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens

      PSYCHOPHARMACOLOGY
    12. Kelly, JJ; Davis, PG; Henschke, PN
      The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre

      JOURNAL OF PAEDIATRICS AND CHILD HEALTH
    13. Garrido, MJ; Aguirre, C; Troconiz, IF; Marot, M; Valle, M; Zamacona, MK; Calvo, R
      Alpha(1)-acid glycoprotein (AAG) and serum protein binding of methadone inheroin addicts with abstinence syndrome

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    14. George, TP; Verrico, CD; Xu, L; Roth, RH
      Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms

      NEUROPSYCHOPHARMACOLOGY
    15. Fischer, G; Eder, H; Peternell, A; Windhaber, J
      Quality of life in pregnant substance dependent women undergoing opioid maintenance therapy

      NERVENHEILKUNDE
    16. Yankovskis, G; Beldava, I; Livina, B
      Osteoreflectory treatment of alcohol abstinence syndrome and craving for alcohol in patients with alcoholism

      ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH
    17. Cui, CL; Wu, LZ; Han, JS
      Spinal kappa-opioid system plays an important role in suppressing morphinewithdrawal syndrome in the rat

      NEUROSCIENCE LETTERS
    18. Hildebrand, BE; Svensson, TH
      Intraaccumbal mecamylamine infusion does not affect dopamine output in thenucleus accumbens of chronically nicotine-treated rats

      JOURNAL OF NEURAL TRANSMISSION
    19. Su, RB; Li, J; Gao, K; Pei, G; Qin, BY
      Influence of idazoxan on analgesia, tolerance, and physical dependence of morphine in mice and rats in vivo

      ACTA PHARMACOLOGICA SINICA
    20. Gaddnas, H; Pietila, K; Ahtee, L
      Effects of chronic oral nicotine treatment and its withdrawal on locomotoractivity and brain monoamines in mice

      BEHAVIOURAL BRAIN RESEARCH
    21. Balfour, DJK; Wright, AE; Benwell, MEM; Birrell, CE
      The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence

      BEHAVIOURAL BRAIN RESEARCH
    22. Uzbay, IT; Yesilyurt, O; Celik, T; Ergun, H; Isimer, A
      Effects of agmatine on ethanol withdrawal syndrome in rats

      BEHAVIOURAL BRAIN RESEARCH
    23. Malin, DH; Moon, WD; Moy, ET; Jennings, RE; Moy, DM; Warner, RL; Wilson, OB
      A rodent model of cocaine abstinence syndrome

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    24. Tobias, JD
      Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit

      CRITICAL CARE MEDICINE
    25. Ziegler, M; Poustka, F; von Loewenich, V; Englert, E
      Post partum risk factors in the development of children born to opiate-addicted mothers: comparison between mothers with and without methadone treatment

      NERVENARZT
    26. Watkins, SS; Stinus, L; Koob, GF; Markou, A
      Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    27. Nakagawa, T; Masuda, T; Watanabe, T; Minami, M; Satoh, M
      Possible involvement of the locus coeruleus in inhibition by prostanoid EP3 receptor-selective agonists of morphine withdrawal syndrome in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Beardsley, PM; Martin, BR
      Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Rodrigo, MDB; Rodriguez, MA; Garcia, MLL; Llera, JLG
      Nevirapine induces abstinence symptoms among HIV-infected patients on a methadone maintenance programme

      REVISTA CLINICA ESPANOLA
    30. Malin, DH; Lake, JR; Moon, WD; Moy, D; Montellano, AL; Moy, E; Campbell, TD; Bell, MV; Bryant, D; Harrison, LM; Grandy, DK
      Nociceptin/orphanin FQ (N/OFQ) induces a quasi-morphine abstinence syndrome in the rat

      PSYCHOPHARMACOLOGY
    31. Ise, Y; Narita, M; Nagase, H; Suzuki, T
      Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats

      PSYCHOPHARMACOLOGY
    32. Costa, B; Giagnoni, G; Colleoni, M
      Precipitated and spontaneous withdrawal in rats tolerant to anandamide

      PSYCHOPHARMACOLOGY
    33. Mansbach, RS; Chambers, LK; Rovetti, CC
      Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine

      PSYCHOPHARMACOLOGY
    34. Fischer, G; Jagsch, R; Eder, H; Gombas, W; Etzersdorfer, P; Schmidl-Mohl, K; Schatten, C; Weninger, M; Aschauer, HN
      Comparison of methadone and slow-release morphine maintenance in pregnant addicts

      ADDICTION
    35. Jernite, M; Viville, B; Escande, B; Brettes, JP; Messer, J
      Buprenorphine and pregnancy. Analysis of 24 cases

      ARCHIVES DE PEDIATRIE
    36. Hildebrand, BE; Panagis, G; Svensson, TH; Nomikos, GG
      Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: Role of nicotinic receptors in the ventral tegmental area

      NEUROPSYCHOPHARMACOLOGY
    37. Tan, PPC; Chen, JC; Li, JY; Liang, KW; Wong, CH; Huang, EYK
      Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs

      PEPTIDES
    38. Limoge, A; Robert, C; Stanley, TH
      Transcutaneous cranial electrical stimulation (TCES): A review 1998

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    39. Bauer, CR
      Perinatal effects of prenatal drug exposure - Neonatal aspects

      CLINICS IN PERINATOLOGY
    40. Kandall, SR
      Treatment strategies for drug-exposed neonates

      CLINICS IN PERINATOLOGY
    41. Watkins, SS; Epping-Jordan, MP; Koob, GF; Markou, A
      Blockade of nicotine self-administration with nicotinic antagonists in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    42. Rossetti, ZL; Isola, D; De Vry, J; Fadda, F
      Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal

      NEUROPHARMACOLOGY
    43. Sepulveda, J; Astorga, JG; Contreras, E
      Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    44. Raghavendra, V; Kulkarni, SK
      Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors

      BRAIN RESEARCH
    45. Brauer, LH; Behm, FM; Westman, EC; Patel, P; Rose, JE
      Naltrexone blockade of nicotine effects in cigarette smokers

      PSYCHOPHARMACOLOGY
    46. Hutchison, KE; Monti, PM; Rohsenow, DJ; Swift, RM; Colby, SM; Gnys, M; Niaura, RS; Sirota, AD
      Effects of naltrexone with nicotine replacement on smoking cue reactivity:preliminary results

      PSYCHOPHARMACOLOGY
    47. WEINTRAUB Z; BENTAL Y; OLIVAN A; ROTSCHILD A
      NEONATAL WITHDRAWAL SYNDROME AND BEHAVIORAL-EFFECTS PRODUCED BY MATERNAL DRUG-USE

      Addiction biology
    48. SAYIN U; ATASOY S; UZBAY IT; ARICIOGLUKARTAL F; KOYUNCUOGLU H
      GAMMA-VINYL-GABA POTENTIATES THE SEVERITY OF NALOXONE-PRECIPITATED ABSTINENCE SIGNS IN MORPHINE-DEPENDENT RATS

      Pharmacological research
    49. FISCHER G; ETZERSDORFER P; EDER H; JAGSCH R; LANGER M; WENINGER M
      BUPRENORPHINE MAINTENANCE IN PREGNANT OPIATE ADDICTS

      European addiction research
    50. MARKOU A; KOSTEN TR; KOOB GF
      NEUROBIOLOGICAL SIMILARITIES IN DEPRESSION AND DRUG-DEPENDENCE - A SELF-MEDICATION HYPOTHESIS

      Neuropsychopharmacology
    51. DEHPOUR AR; MEYSAMI F; EBRAHIMIDARYANI N; AKBARLOO N
      INHIBITION BY LITHIUM OF OPIOID WITHDRAWAL-LIKE SYNDROME AND PHYSICALDEPENDENCY IN A MODEL OF ACUTE CHOLESTASIS IN MICE

      Human psychopharmacology
    52. PICCIOTTO MR
      COMMON ASPECTS OF THE ACTION OF NICOTINE AND OTHER DRUGS OF ABUSE

      Drug and alcohol dependence
    53. PINELLI A; TRIVULZIO S; SPEZIA R
      EFFECTS OF TIZANIDINE ADMINISTRATION ON PRECIPITATED OPIOID WITHDRAWAL SIGNS IN RATS

      Drug and alcohol dependence
    54. RASMUSSEN DD
      EFFECTS OF CHRONIC NICOTINE TREATMENT AND WITHDRAWAL ON HYPOTHALAMIC PROOPIOMELANOCORTIN GENE-EXPRESSION AND NEUROENDOCRINE REGULATION

      Psychoneuroendocrinology
    55. POMERLEAU OF
      ENDOGENOUS OPIOIDS AND SMOKING - A REVIEW OF PROGRESS AND PROBLEMS

      Psychoneuroendocrinology
    56. BHARGAVA HN; KUMAR S; BARJAVEL MJ
      KINETIC-PROPERTIES OF NITRIC-OXIDE SYNTHASE IN CEREBRAL-CORTEX AND CEREBELLUM OF MORPHINE-TOLERANT MICE

      Pharmacology
    57. BERLIN CM; MCCARVER DG; NOTTERMAN DA; WARD RM; WEISMANN DN; WILSON GS; WILSON JT; BENNETT DR; HOSKINS IA; KAUFMAN P; MITHANI S; MULINARE J; MACLEOD SM; TROENDLE G; MARCH J; YAFFE SJ; SZEFLER SJ; COTE CJ
      NEONATAL DRUG-WITHDRAWAL

      Pediatrics
    58. FABRIS C; PRANDI G; PERATHONER C; SOLDI A
      NEONATAL DRUG-ADDICTION

      Panminerva Medica
    59. EPPINGJORDAN MP; WATKINS SS; KOOB GF; MARKOU A
      DRAMATIC DECREASES IN BRAIN REWARD FUNCTION DURING NICOTINE WITHDRAWAL

      Nature
    60. ADAMS ML; CICERO TJ
      NITRIC-OXIDE MEDIATES MECAMYLAMINE-PRECIPITATED AND NALOXONE-PRECIPITATED NICOTINE WITHDRAWAL

      European journal of pharmacology
    61. GELOT A; FRANCES B; ROUSSIN A; LATAPIE JP; ZAJAC JM
      ANTI-OPIOID EFFICACY OF NEUROPEPTIDE FF IN MORPHINE-TOLERANT MICE

      Brain research
    62. LEITEMORRIS KA; KAPLAN GB; SMITH JG; SEARS MT
      REGULATION OF G-PROTEINS AND ADENYLYL-CYCLASE IN BRAIN-REGIONS OF CAFFEINE-TOLERANT AND CAFFEINE-DEPENDENT MICE

      Brain research
    63. HILDEBRAND BE; NOMIKOS GG; HERTEL P; SCHILSTROM B; SVENSSON TH
      REDUCED DOPAMINE OUTPUT IN THE NUCLEUS-ACCUMBENS BUT NOT IN THE MEDIAL PREFRONTAL CORTEX IN RATS DISPLAYING A MECAMYLAMINE-PRECIPITATED NICOTINE WITHDRAWAL SYNDROME

      Brain research
    64. PINELLI A; TRIVULZIO S
      QUANTITATIVE-EVALUATION OF OPIOID WITHDRAWAL SIGNS IN RATS REPEATEDLYTREATED WITH MORPHINE AND INJECTED WITH NALOXONE, IN THE ABSENCE OR PRESENCE OF THE ANTIABSTINENCE AGENT CLONIDINE

      Journal of pharmacological and toxicological methods
    65. ZARRINDAST MR; PAZOUKI M; NASSIRIRAD S
      INVOLVEMENT OF CHOLINERGIC AND OPIOID RECEPTOR MECHANISMS IN NICOTINE-INDUCED ANTINOCICEPTION

      Pharmacology & toxicology
    66. KOOB GF; NESTLER EJ
      THE NEUROBIOLOGY OF DRUG-ADDICTION

      The Journal of neuropsychiatry and clinical neurosciences
    67. WOJNARHORTON RE; KRISTENSEN JH; YAPP P; ILETT KF; DUSCI LJ; HACKETT LP
      METHADONE DISTRIBUTION AND EXCRETION INTO BREAST-MILK OF CLIENTS IN AMETHADONE-MAINTENANCE PROGRAM

      British journal of clinical pharmacology
    68. KUMAR S; BHARGAVA HN
      TIME-COURSE OF THE CHANGES IN CENTRAL NITRIC-OXIDE SYNTHASE ACTIVITY FOLLOWING CHRONIC TREATMENT WITH MORPHINE IN THE MOUSE - REVERSAL BY NALTREXONE

      General pharmacology
    69. BHARGAVA HN; CAO YJ; ZHAO GM
      EFFECT OF 7-NITROINDAZOLE ON TOLERANCE TO MORPHINE, U-50,488H AND [D-PEN(2), D-PEN(5)] ENKEPHALIN IN MICE

      Peptides
    70. BHARGAVA HN; CAO YJ
      EFFECT OF CHRONIC ADMINISTRATION OF MORPHINE, U-50, 488H AND [D-PEN(2), D-PEN(5)]ENKEPHALIN ON THE CONCENTRATION OF CGMP IN BRAIN-REGIONS AND SPINAL-CORD OF THE MOUSE

      Peptides
    71. BUSQUETS X; VENTAYOL P; GARCIASEVILLA JA
      NALOXONE-PRECIPITATED WITHDRAWAL IN MORPHINE-DEPENDENT RATS INCREASESTHE EXPRESSION OF ALPHA(2A)-ADRENOCEPTOR MESSENGER-RNA IN BRAIN

      Molecular brain research
    72. MAYOSMITH MF
      PHARMACOLOGICAL MANAGEMENT OF ALCOHOL-WITHDRAWAL - A METAANALYSIS ANDEVIDENCE-BASED PRACTICE GUIDELINE

      JAMA, the journal of the American Medical Association
    73. MUCHA RF
      PREFERENCES FOR TASTES PAIRED WITH A NICOTINE ANTAGONIST IN RATS CHRONICALLY TREATED WITH NICOTINE

      Pharmacology, biochemistry and behavior
    74. SAITZ R; OMALLEY SS
      PHARMACOTHERAPIES FOR ALCOHOL-ABUSE - WITHDRAWAL AND TREATMENT

      The Medical clinics of North America
    75. ARICIOGLUKARTAL F; UZBAY IT
      INHIBITORY EFFECT OF AGMATINE ON NALOXONE-PRECIPITATED ABSTINENCE SYNDROME IN MORPHINE-DEPENDENT RATS

      Life sciences
    76. PINELLI A; TRIVULZIO S; TOMASONI L
      EFFECTS OF ADMINISTRATION OF PHENTONIUM BROMIDE ON OPIOID WITHDRAWAL SYNDROME IN RATS

      Journal of Pharmacy and Pharmacology
    77. BRANDOM BW
      POSTOPERATIVE MANAGEMENT OF LARYNGOTRACHEAL RECONSTRUCTION

      International anesthesiology clinics
    78. PINELLI A; TRIVULZIO S; TOMASONI L
      EFFECTS OF ONDANSETRON ADMINISTRATION ON OPIOID WITHDRAWAL SYNDROME OBSERVED IN RATS

      European journal of pharmacology
    79. MCLEMORE GL; KEST B; INTURRISI CE
      THE EFFECTS OF LY293558, AN AMPA RECEPTOR ANTAGONIST, ON ACUTE AND CHRONIC MORPHINE-DEPENDENCE

      Brain research
    80. CAO YJ; BHARGAVA HN
      EFFECTS OF IBOGAINE ON THE DEVELOPMENT OF TOLERANCE TO ANTINOCICEPTIVE ACTION OF MU-OPIOID, DELTA-OPIOID AND KAPPA-OPIOID RECEPTOR AGONISTSIN MICE

      Brain research
    81. BHARGAVA HN; THORAT SN
      DIFFERENTIAL-EFFECTS OF LY235959, A COMPETITIVE ANTAGONIST OF THE NMDA RECEPTOR ON KAPPA-OPIOID RECEPTOR AGONIST-INDUCED RESPONSES IN MICE AND RATS

      Brain research
    82. PICKWORTH WB; FANT RV; BUTSCHKY MF; GOFFMAN AL; HENNINGFIELD JE
      EVALUATION OF CRANIAL ELECTROSTIMULATION THERAPY ON SHORT-TERM SMOKING CESSATION

      Biological psychiatry
    83. THEIS JGW; SELBY P; IKIZLER Y; KOREN G
      CURRENT MANAGEMENT OF THE NEONATAL ABSTINENCE SYNDROME - A CRITICAL ANALYSIS OF THE EVIDENCE

      Biology of the neonate
    84. KHAN K; CHANG J
      NEONATAL ABSTINENCE SYNDROME DUE TO CODEINE

      Archives of Disease in Childhood
    85. KUNZE M
      EPIDEMIOLOGY OF NICOTINE DEPENDENCE AND GENERAL-ASPECTS OF SMOKING CESSATION

      Cardiovascular risk factors
    86. WIESBECK GA; SCHUCKIT MA; KALMIJN JA; TIPP JE; BUCHOLZ KK; SMITH TL
      AN EVALUATION OF THE HISTORY OF A MARIJUANA WITHDRAWAL SYNDROME IN A LARGE POPULATION

      Addiction
    87. DAPOLITO KC; MCRORIE TI
      PHARMACOLOGICAL MANAGEMENT OF NEONATAL ABSTINENCE SYNDROME

      The Journal of perinatal & neonatal nursing
    88. MORRISON CL; SINEY C
      A SURVEY OF THE MANAGEMENT OF NEONATAL OPIATE WITHDRAWAL IN ENGLAND AND WALES

      European journal of pediatrics
    89. BAHWERE P; HAUMONT D; DELANGE F
      CONGENITAL HYPOTHYROIDISM AND NEONATAL WITHDRAWAL SYNDROME

      European journal of pediatrics
    90. PEPPERS MP
      BENZODIAZEPINES FOR ALCOHOL-WITHDRAWAL IN THE ELDERLY AND IN PATIENTSWITH LIVER-DISEASE

      Pharmacotherapy
    91. GERRA G; GIUCASTO G; ZAIMOVIC A; FERTONANI G; CHITTOLINI B; AVANZINI P; CACCAVARI R; DELSIGNORE R
      INTRAVENOUS FLUMAZENIL FOLLOWING PROLONGED EXPOSURE TO LORMETAZEPAM IN HUMANS - LACK OF PRECIPITATED WITHDRAWAL

      International clinical psychopharmacology
    92. MALIN DH; LAKE JR; JONES JA; MOREL J; MOON WD; CORBIT BP; SMITH DA; CLAUNCH AE; KACHER D; STEVENS PA; WEBB SL
      NITRIC-OXIDE SYNTHESIS INHIBITION ATTENUATES BEHAVIORAL ACTIONS OF NEUROPEPTIDE FF

      Peptides
    93. MALIN DH; LAKE JR; MCDERMITT LS; SMITH DA; WITHERSPOON WE; JONES JA; SCHUMANN MD; PAYZA K; HO KK; BURGESS K
      ENHANCED ANTIOPIATE ACTIVITY AND ENZYME RESISTANCE IN A PEPTIDOMIMETIC OF FMRFAMIDE CONTAINING E-2,3-METHANOMETHIONINE AND E-2,3-METHANOPHENYLALANINE

      Peptides
    94. GUDEHITHLU KP; BHARGAVA HN
      MODIFICATION OF THE CHARACTERISTICS OF DOPAMINE TRANSPORTER IN BRAIN-REGIONS AND SPINAL-CORD OF MORPHINE-TOLERANT AND ABSTINENT RATS

      Neuropharmacology
    95. HEINRICHS SC; LAPSANSKY J; BEHAN DP; CHAN RKW; SAWCHENKO PE; LORANG M; LING N; VALE WW; DESOUZA EB
      CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN LIGAND INHIBITOR BLUNTS EXCESSIVE WEIGHT-GAIN IN GENETICALLY-OBESE ZUCKER RATS AND RATS DURING NICOTINE WITHDRAWAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    96. ACETO MD; SCATES SM; LOWE JA; MARTIN BR
      DEPENDENCE ON DELTA(9)-TETRAHYDROCANNABINOL - STUDIES ON PRECIPITATEDAND ABRUPT WITHDRAWAL

      The Journal of pharmacology and experimental therapeutics
    97. SUZUKI T; ISE Y; TSUDA M; MAEDA J; MISAWA M
      MECAMYLAMINE-PRECIPITATED NICOTINE-WITHDRAWAL AVERSION IN RATS

      European journal of pharmacology
    98. TENENBEIN M; CASIRO OG; SESHIA MMK; DEBOOY VD
      NEONATAL WITHDRAWAL FROM MATERNAL VOLATILE SUBSTANCE-ABUSE

      Archives of Disease in Childhood
    99. KAPLAN GB; SEARS MT
      ADENOSINE RECEPTOR AGONISTS ATTENUATE AND ADENOSINE RECEPTOR ANTAGONISTS EXACERBATE OPIATE WITHDRAWAL SIGNS

      Psychopharmacology
    100. KOYUNCUOGLU H
      THE COMBINATION OF TIZANIDINE MARKEDLY IMPROVES THE TREATMENT WITH DEXTROMETHORPHAN OF HEROIN ADDICTED OUTPATIENTS

      International journal of clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 04:04:21